Atrial Fibrillation Market by Treatment Type (Pharmacological – Anti-Arrhythmic Drugs, Anti-Coagulant Drugs and Non-Pharmacological  – Catheter Ablation based on Cryoablation, HIFU, Laser, Microwave and Radiofrequency, Maze Surgery, and Electric Cardioversion) and Forecast 2017-2021

Atrial Fibrillation Market by Treatment Type (Pharmacological – Anti-Arrhythmic Drugs, Anti-Coagulant Drugs and Non-Pharmacological  – Catheter Ablation based on Cryoablation, HIFU, Laser, Microwave and Radiofrequency, Maze Surgery, and Electric Cardioversion) and Forecast 2017-2021

Atrial fibrillation (A-Fib or AF) involves quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Treatments for atrial fibrillation may include medications and other interventions to try to alter the heart’s electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions, and are potentially life threatening and expensive to treat.

The global atrial fibrillation market report provides market size estimates (Revenue US$ million – 2014 to 2021) for key market segments based on treatment type (pharmacological – anti-arrhythmic drugs, anti-coagulant drugs and non-pharmacological  – catheter ablation based on cryoablation, HIFU, laser, microwave and radiofrequency, maze surgery, and electric cardioversion), and forecasts growth trends (CAGR% – 2017 to 2021).

The global atrial fibrillation market segmentation is based on geography (regional and country based). The global atrial fibrillation market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global atrial fibrillation market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global atrial fibrillation market and profiled in the report are St. Jude Medical, Boehringer Ingelheim, Boston Scientific Corporation, AtriCure, Inc., Johnson & Johnson and Bayer (Xeralto), Sanofi, CardioFocus, Endoscopic Technologies, Bristol Myers-Pfizer, Biosense Wesbter and others.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue US$ Million, 2014-2021)
    • Forecast Estimation (Revenue US$ Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Atrial Fibrillation Market

1. Treatment Type
1.1. Pharmacological Treatment
1.1.1. Anti-Arrhythmic Drugs
1.1.2. Anti-Coagulant Drugs
1.2. Non-Pharmacological Treatment
1.2.1. Catheter Ablation
1.2.1.1. Cryoablation Based
1.2.1.2. HIFU (High Intensity Focused Ultrasound) Based
1.2.1.3. Laser Based
1.2.1.4. Microwave Based
1.2.1.5. Radiofrequency Based
1.2.2. Maze Surgery
1.2.3. Electric Cardioversion

2. Company Profiles
3. AtriCure, Inc.
4. Biosense Webster, Inc.
5. Boehringer Ingelheim GmbH
6. Boston Scientific Corporation
7. Bristol-Myers Squibb Corporation
8. CardioFocus, Inc.
9. Endoscopic Technologies, Inc.
10. Sanofi Aventis
11. St. Jude Medical, Inc.
12. Johnson and Johnson Ltd.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*